Clinical markers of post-Chikungunya chronic inflammatory joint disease: A Brazilian cohort
PLOS Neglected Tropical Diseases · 2023
DOI: 10.1371/journal.pntd.0011037 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2023. Verfasst von Carolina Dos Santos Lázari und 17 weiteren Autor:innen. Beteiligte Einrichtung: Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Chikungunya Fever, Arthritis, Synovitis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, Fundação de Amparo à Pesquisa do Estado de São Paulo-Universidade de São Paulo-bioMérieux S.A. – PITE2 ARBOBIOS.
Abstract (Originalsprache)
Background
Chikungunya-fever (CHIKF) remains a public health major issue. It is clinically divided into three phases: acute, post-acute and chronic. Chronic cases correspond to 25–40% individuals and, though most of them are characterized by long-lasting arthralgia alone, many of them exhibit persistent or recurrent inflammatory signs that define post-Chikungunya chronic inflammatory joint disease (pCHIKV-CIJD). We aimed to identify early clinical markers of evolution to pCHIKV-CIJD during acute and post-acute phases. Methodology/Principal findings We studied a prospective cohort of CHIKF-confirmed volunteers with longitudinal clinical data collection from symptoms onset up to 90 days, including a 21-day visit (D21). Of 169 patients with CHIKF, 86 (50.9%) completed the follow-up, from whom 39 met clinical criteria for pCHIKV-CIJD (45.3%). The relative risk of chronification was higher in women compared to men (RR = 1.52; 95% CI = 1.15–1.99; FDR = 0.03). None of the symptoms or signs presented at D0 behaved as an early predictor of pCHIKV-CIJD, while being symptomatic at D21 was a risk factor for chronification (RR = 1.31; 95% CI = 1.09–1.55; FDR = 0.03). Significance was also observed for joint pain (RR = 1.35; 95% CI = 1.12–1.61; FDR = 0.02), reported edema (RR = 3.61; 95% CI = 1.44–9.06; FDR = 0.03), reported hand and/or feet small joints edema (RR = 4.22; 95% CI = 1.51–11.78; FDR = 0.02), and peri-articular edema observed during physical examination (RR = 2.89; 95% CI = 1.58–5.28; FDR = 0.002). Furthermore, patients with no findings in physical examination at D21 were at lower risk of chronic evolution (RR = 0.41, 95% CI = 0.24–0.70, FDR = 0.01). Twenty-nine pCHIKV-CIJD patients had abnormal articular ultrasonography (90.6% of the examined). The most common findings were synovitis (65.5%) and joint effusion (58.6%).
Conclusion
This cohort has provided important insights into the prognostic evaluation of CHIKF. Symptomatic sub-acute disease is a relevant predictor of evolution to chronic arthritis with synovitis, drawing attention to joint pain, edema, multiple articular involvement including small hand and feet joints as risk factors for chronification beyond three months, especially in women. Future studies are needed to accomplish the identification of accurate and early biomarkers of poor clinical prognosis, which would allow better understanding of the disease’s evolution and improve patients’ management, modifying CHIKF burden on global public health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
- Fleury Medicina e Saúde, São Paulo, Brazil.
- Departamento de Moléstias Infecciosas e Parasitárias, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
- Instituto de Medicina Tropical, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
- Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
- Open Innovation and Partnerships, bioMérieux SA, Lyon, France.
ORCID-Profile: Mariana Severo Ramundo
Förderung
- Wellcome Trust
- Medical Research Council
- Fundação de Amparo à Pesquisa do Estado de São Paulo-Universidade de São Paulo-bioMérieux S.A. – PITE2 ARBOBIOS
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação Faculdade de Medicina da Universidade de São Paulo
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Wellcome Trust and Royal Society Sir Henry Dale Fellowship
Zitieren
APA
Lázari, C. D. S., Ramundo, M. S., Ten-Caten, F., Bressan, C. S., de Filippis, A. M. B., Manuli, E. R., de Moraes, I., Pereira, G. M., Côrtes, M. F., Candido, D. D. S., Gerber, A. L., Guimarães, A. P., Faria, N. R., Nakaya, H. I., Vasconcelos, A. T. R., Brasil, P., Paranhos-Baccalà, G., & Sabino, E. C. (2023). Clinical markers of post-Chikungunya chronic inflammatory joint disease: A Brazilian cohort. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011037
Vancouver
Lázari CDS, Ramundo MS, Ten-Caten F, Bressan CS, de Filippis AMB, Manuli ER, et al. Clinical markers of post-Chikungunya chronic inflammatory joint disease: A Brazilian cohort. PLOS Neglected Tropical Diseases. 2023. doi:10.1371/journal.pntd.0011037
BibTeX
@article{Lzari2023,
author = {Lázari, Carolina Dos Santos and Ramundo, Mariana Severo and Ten-Caten, Felipe and Bressan, Clarisse S and de Filippis, Ana Maria Bispo and Manuli, Erika Regina and de Moraes, Isabella and Pereira, Geovana Maria and Côrtes, Marina Farrel and Candido, Darlan da Silva and Gerber, Alexandra L and Guimarães, Ana Paula and Faria, Nuno Rodrigues and Nakaya, Helder I and Vasconcelos, Ana Tereza R and Brasil, Patrícia and Paranhos-Baccalà, Gláucia and Sabino, Ester Cerdeira},
title = {Clinical markers of post-Chikungunya chronic inflammatory joint disease: A Brazilian cohort},
journal = {PLOS Neglected Tropical Diseases},
year = {2023},
doi = {10.1371/journal.pntd.0011037}
}
EUVIMED